According to Ryman Healthcare's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.4153. At the end of 2023 the company had a P/S ratio of 6.57.
Year | P/S ratio | Change |
---|---|---|
2023 | 6.57 | -29.47% |
2022 | 9.31 | -44.94% |
2021 | 16.9 | 38.6% |
2020 | 12.2 | -23.64% |
2019 | 16.0 | 2.87% |
2018 | 15.5 | 6.53% |
2017 | 14.6 | -8.81% |
2016 | 16.0 | -7.91% |
2015 | 17.4 | -19.87% |
2014 | 21.7 | 55.13% |
2013 | 14.0 | 40.13% |
2012 | 9.97 | 8.6% |
2011 | 9.18 | -3.25% |
2010 | 9.49 | 23.73% |
2009 | 7.67 | -32.98% |
2008 | 11.4 | 94.32% |
2007 | 5.89 | 25.95% |
2006 | 4.67 | 46.31% |
2005 | 3.20 | 56.86% |
2004 | 2.04 | 25.69% |
2003 | 1.62 | -43.27% |
2002 | 2.86 | -16.84% |
2001 | 3.44 |